Development and Validation of an IA-LC/MS Method to Quantitate Active and Total B-Type Natriuretic Peptide in Human Plasma

References

• LaPointe MC . Molecular regulation of the brain natriuretic peptide gene. Peptides26 (6), 944–956 (2005).
   PubMed Web of Science ®Google Scholar
• Yasue H , YoshimuraM, SumidaHet al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation90 (1), 195–203 (1994).
   PubMed Web of Science ®Google Scholar
• Clerico A , VittoriniS, PassinoC. Circulating forms of the B-type natriuretic peptide prohormone: pathophysiologic and clinical considerations. Adv. Clin. Chem. 58, 31–44 (2012).
   PubMed Web of Science ®Google Scholar
• Francis GS , FelkerGM, TangWH. A test in context: critical evaluation of natriuretic peptide testing in heart failure. J. Am. Coll. Cardiol. 67 (3), 330–337 (2016).
   PubMed Web of Science ®Google Scholar
• Nawaytou H , BernsteinHS. Biomarkers in pediatric heart disease. Biomark. Med. 8 (7), 943–963 (2014).
   PubMed Web of Science ®Google Scholar
• Maisel A , MuellerC, AdamsKJret al. State of the art: using natriuretic peptide levels in clinical practice. Eur. J. Heart Fail. 10 (9), 824–839 (2008).
   PubMed Web of Science ®Google Scholar
• Gaggin HK , JanuzziJLJr. Biomarkers and diagnostics in heart failure. Biochim. Biophys. Acta1832 (12), 2442–2450 (2013).
   PubMed Web of Science ®Google Scholar
• Maisel AS , KrishnaswamyP, NowakRMet al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347 (3), 161–167 (2002).
   PubMed Web of Science ®Google Scholar
• Sykes E , KarcherRE, EisenstadtJet al. Analytical relationships among Biosite, Bayer, and Roche methods for BNP and NT-proBNP. Am. J. Clin. Pathol. 123 (4), 584–590 (2005).
   PubMed Web of Science ®Google Scholar
• Tang WH , FrancisGS, MorrowDAet al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Clin. Biochem. 41 (4–5), 210–221 (2008).
   PubMed Web of Science ®Google Scholar
• Goetze JP , KastrupJ, RehfeldJF. The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure?Eur. Heart J. 24 (16), 1471–1472 (2003).
   PubMed Web of Science ®Google Scholar
• Liang F , O’RearJ, SchellenbergerUet al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J. Am. Coll. Cardiol. 49 (10), 1071–1078 (2007).
   PubMed Web of Science ®Google Scholar
• Andrews GL , ShufordCM, BurnettJCJr, HawkridgeAM, MuddimanDC. Coupling of a vented column with splitless nanoRPLC-ESI-MS for the improved separation and detection of brain natriuretic peptide-32 and its proteolytic peptides. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 (10), 948–954 (2009).
   PubMed Web of Science ®Google Scholar
• Hawkridge AM , HeubleinDM, BergenHRIII, CataliottiA, BurnettJCJr, MuddimanDC. Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc. Natl Acad. Sci. USA102 (48), 17442–17447 (2005).
   PubMed Web of Science ®Google Scholar
• Mesmin C , RenvoiseM, BecherF, EzanE, FenailleF. MS-based approaches to unravel the molecular complexity of proprotein-derived biomarkers and support their quantification: the examples of B-type natriuretic peptide and apelin peptides. Bioanalysis4 (23), 2851–2863 (2012).
   PubMed Web of Science ®Google Scholar
• Miller WL , PhelpsMA, WoodCMet al. Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure. Circ. Heart Fail. 4 (3), 355–360 (2011).
   PubMed Web of Science ®Google Scholar
• Niederkofler EE , KiernanUA, O’RearJet al. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure. Circ. Heart Fail. 1 (4), 258–264 (2008).
   PubMed Web of Science ®Google Scholar
• Shuford CM , CominsDL, WhittenJL, BurnettJCJr, MuddimanDC. Improving limits of detection for B-type natriuretic peptide using PC-IDMS: an application of the ALiPHAT strategy. Analyst135 (1), 36–41 (2010).
   PubMed Web of Science ®Google Scholar
• Arnold ME , BoothB, KingL, RayC. Workshop report: Crystal City VI – bioanalytical method validation for biomarkers. AAPS J. doi: 10.1208/s12248-016-9946-6 (2016) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Brandt I , LambeirAM, KetelslegersJM, VanderheydenM, ScharpeS, De MeesterI. Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clin. Chem. 52 (1), 82–87 (2006).
   PubMed Web of Science ®Google Scholar
• Pankow K , WangY, GembardtFet al. Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide. Circ. Res. 101 (9), 875–882 (2007).
   PubMed Web of Science ®Google Scholar
• Vanderheyden M , BartunekJ, GoethalsMet al. Dipeptidyl-peptidase IV and B-type natriuretic peptide. from bench to bedside. Clin. Chem. Lab Med. 47 (3), 248–252 (2009).
   PubMed Web of Science ®Google Scholar
• Yandle TG , RichardsAM. B-type natriuretic peptide circulating forms: analytical and bioactivity issues. Clin. Chim. Acta448, 195–205 (2015).
   PubMed Web of Science ®Google Scholar
• Balion C , Don-WauchopeA, HillSet al. Use of Natriuretic Peptide Measurement in the Management of Heart Failure. Comparative Effectiveness Review No. 126 (Prepared by the McMaster University Evidence-based Practice Center Under Contract No. 290-2007-10060-I) . AHRQ publication no. 13(14)-EHC118-EF. Agency for Healthcare Research and Quality, Rockville, MD, USA (2013).
   Google Scholar
• Seferian KR , TammNN, SemenovAGet al. The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure. Clin. Chem. 53 (5), 866–873 (2007).
   PubMed Web of Science ®Google Scholar